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Summary
Batrachochytrium salamandrivorans (Bsal) poses a major threat to amphibian, and
more specifically caudata, diversity. Bsal is currently spreading through Europe, and
mitigation measures aimed at stopping its spread and preventing its introduction
into na€ıve environments are urgently needed. Screening for presence of Bsal and
diagnosis of Bsal-induced disease in amphibians are essential core components of
effective mitigation plans. Therefore, the aim of this study was to present an over-
view of all Bsal diagnostic tools together with their limitations and to suggest guide-
lines to allow uniform interpretation. Here, we investigate the use of different
diagnostic tools in post-mortem detection of Bsal and whether competition between
Bd and Bsal occurs in the species-specific Bd and Bsal duplex real-time PCR. We
also investigate the diagnostic sensitivity, diagnostic specificity and reproducibility
of the Bsal real-time PCR and show the use of immunohistochemistry in diagnosis
of Bsal-induced chytridiomycosis in amphibian samples stored in formaldehyde.
Additionally, we have drawn up guidelines for the use and interpretation of the dif-
ferent diagnostic tools for Bsal currently available, to facilitate standardization of
execution and interpretation.
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1 | INTRODUCTION
Amphibians are the most threatened class of vertebrates in the
midst of the biodiversity crisis the world is currently experiencing
(Stuart et al., 2004). Underlying factors such as loss of habitat, pollu-
tion and infectious disease are continuously pressuring the survival
of amphibian populations and species around the world (Catenazzi,
2015). Among the major infectious diseases, negatively impacting
amphibian survival in the wild is the recently described chytrid fun-
gus Batrachochytrium salamandrivorans (Bsal), which like its closest
relative Batrachochytrium dendrobatidis (Bd), is able to cause the
lethal skin disease chytridiomycosis in amphibians (Longcore, Pessier,
& Nichols, 1999; Martel et al., 2013). While Bd has been associated
with chytridiomycosis in species of all amphibian orders (Anura, Cau-
data, Gymnophiona), Bsal-induced chytridiomycosis has so far only
been found in amphibian species belonging to Caudata (Van Rooij,
Martel, Haesebrouck, & Pasmans, 2015). Species are therefore at
risk; in case, Bsal should be introduced (Richgels, Russell, Adams,
White, & Grant, 2016; Yap, Koo, Ambrose, Wake, & Vredenburg,
2015).
While surveillance efforts have shown that Bd has globalized, the
only wild amphibian populations in which Bsal has been detected so
far have been in Europe, where it is spreading and causing disease
outbreaks in a wavelike pattern (Spitzen-van der Sluijs et al., 2016),
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and in Asia, where to date, no negative impact of the presence of
Bsal has been reported (Laking, Ngo, Pasmans, Martel, & Nguyen,
2017; Martel et al., 2014). However, monitoring for Bsal’s presence
has only recently commenced, and systemic active surveillance of
wild, captive and traded amphibians is needed to map Bsal’s current
distribution. Bsal has been shown to be present in captive amphibian
collections in several European countries (Bletz et al., 2015; Cun-
ningham et al., 2015), and with the knowledge that Bd’s cosmopoli-
tan distribution is very likely facilitated by the trade in Bd-infected
amphibians (Fisher, Garner, & Walker, 2009), it seems only a matter
of time until spread of Bsal to na€ıve regions and continents is
reported (Grant et al., 2016).
The risk posed by Bsal has led governmental and non-govern-
mental organizations to take actions, or to advise policymakers on
implementing emergency action plans for Bsal in order to try to pro-
tect native salamander populations and species. As currently no
methods are available to mitigate the effects of Bsal on natural
amphibian populations once it has emerged, accurately diagnosing
Bsal-induced chytridiomycosis and preventing introduction and
spread of Bsal are crucial elements in emergency action plans (Gar-
ner et al., 2016). Therefore, science-based screening and monitoring
efforts, based on reliable and accurate diagnostic methods, are
essential.
Several diagnostic methods for Bsal detection have been
described including histology/histopathology, PCR, qPCR and lateral
flow technology. However, the limitations of some of these tech-
niques include (i) the need for experienced operators or experts to
perform these assays, (ii) the ability of the tests to only detect and
not quantify the pathogen in samples, (iii) the inability to detect low
numbers of the pathogen and (iv) poor diagnostic sensitivity and
specificity. The Bsal real-time PCR adequately addresses these limita-
tions and is one of the premiere methods for Bsal diagnostics in use.
However, despite being utilized in several countries, the diagnostic
sensitivity, specificity and reproducibility of this assay have not pre-
viously been established based on the criteria of the OIE (EFSA,
2017, OIE, 2016).
The aims of this study were (i) to validate the Bsal-specific real-
time PCR, (ii) to give an overview of the currently available diagnos-
tic tools for Bsal, (iii) to give recommendations on the use of the
duplex real-time PCR and immunohistochemistry, (iv) to give recom-
mendations on most appropriate methods for post-mortem detection
and time frame for post-mortem detection using the duplex real-time
PCR and histopathology and (v) to elucidate the latency period
(elapsed time between pathogen exposure and detectability of Bsal
on the host). These guidelines should promote uniform implementa-
tion and interpretation of Bsal diagnostic tests.
2 | MATERIALS AND METHODS
2.1 | Experimental animals
All experiments with experimental animals were performed with the
approval of the ethical committee of the Faculty of Veterinary
Medicine, Ghent University (EC2011/073, 2015/26, 2015/42,
EC2015/62, EC2015/83). Five fire salamanders (Salamandra salaman-
dra) were experimentally infected with Bsal (type strain AMFP13/1.
A 1 ml suspension containing 105 spores was dripped on each ani-
mal (Martel et al., 2013) used for the experiment examining the
post-mortem detection of Bsal. Twenty-six fire salamanders were
used to investigate the latency time of the Bsal-specific real-time
PCR in detecting infections in fire salamanders exposed to low Bsal
infection dosages (100 spores per ml). Six rabbits were used for pro-
duction of polyclonal antibodies against Bd (type strain JEL423) and
Bsal (type strain AMFP13/1).
2.2 | Post-mortem detection of Bsal
Fire salamanders that died due to Bsal-induced chytridiomycosis
were used to investigate the applicability of the different diagnostic
tools in post-mortem detection of Bsal. Directly after death of an
animal, it was transferred to a passively aerated plastic container
with moist soil and leaf litter to mimic conditions under which dead
Bsal-infected salamanders were found in the field. The containers
were placed in a climate-controlled room set at 15°C. Directly after
death, and after 1, 2, 3, 4, 5, 7 and 10 days, samples (swabs and tis-
sue samples) for detection of Bsal were taken. Each sampling occa-
sion consisted of collecting swabs of the ventral and dorsal skin by
placing a swab on the skin and rotating it in place for 20 full rota-
tions, collecting full thickness single skin samples of the ventral and
dorsal skin with use of a 3-mm biopsy punch (Stiefel, Germany) and
collecting a tail clip of the animal (tissue samples were weighed to
allow correction for variability in tissue size). All samples were taken
from new, unsampled areas of skin to avoid interference in the
detection of Bsal. Swab samples and tail tissues were stored at
20°C and analysed for the presence of Bsal with use of a Bsal-spe-
cific simplex real-time PCR (Blooi et al., 2013). Skin biopsy samples
were stored in formaldehyde and processed for histological examina-
tion (haematoxylin and eosin [HE] stain) for detection of Bsal.
2.3 | Latency time of the Bsal real-time PCR to
detect infections in fire salamanders exposed to a
low dose of Bsal
To investigate the latency time of the Bsal real-time PCR in detect-
ing Bsal infections in fire salamanders that were exposed to a low
dose (100 spores/ml) of Bsal spores, 26 fire salamanders were
exposed to 100 spores of Bsal (Bsal type strain AMFP13/1) and
screened with the Bsal real-time PCR by assaying skin swabs taken
at 7-day intervals. Five animals were included as unexposed negative
controls. Signs of clinical chytridiomycosis (skin ulcerations, anorexia,
apathy) and/or high infection loads (Stegen et al., 2017) with Bsal
(>10,000 GE per swab) as detected with the real-time PCR were
considered as humane endpoints and resulted in the animals being
withdrawn from the experiment and treated with temperature (expo-
sure to 25°C for 10 days) (Blooi et al., 2015). On the day of Bsal
exposure (D0), no swab samples were taken to avoid inference of
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the swabbing facilitating the establishment of Bsal infections in the
animals.
2.4 | Competition between detection of Bd and
Bsal in the duplex real-time PCR
In the duplex real-time PCR, two reactions are occurring in each well
simultaneously. Both reactions require dNTPs, polymerase and other
constituents of the master mix. When duplex real-time PCR is per-
formed on a sample where one target largely outnumbers the other,
the more abundant target outcompetes the other for the reaction
reagents. This results in the less abundant target not being amplified
at the same rate. Occurrence of competition between Bd and Bsal
primers and probes in the Bd- and Bsal-specific duplex real-time PCR
was evaluated by assaying different relative concentrations of Bd
and Bsal DNA. Ten-fold serial dilutions series of both Bd (strain
JEL423) and Bsal (AMFP 13/1) were prepared to achieve concentra-
tions ranging from 1,000 to 0.1 genomic equivalents (GEs) per 5 ll
(all test samples were composed of 1:1 mixtures of Bsal and Bd
zoospore suspensions of 1,000 to 0.1 GE resulting in final concen-
trations of 500 to 0.05 GE) (Blooi et al., 2013). All possible combina-
tions of concentrations of Bd and Bsal were run in a checkerboard
set-up, with final concentrations of both Bd and Bsal ranging from
500 to 0.05 GEs per real-time PCR reaction. All concentrations of
Bd or Bsal were also analysed in the absence of the other pathogen
to establish baseline values for comparison with the duplex real-time
PCR results. Occurrence of competition between detection of Bd
and Bsal was determined based on difference in real-time PCR val-
ues (Ct-values) and abnormal real-time PCR curves. Combinations in
which the difference in Ct-values was smaller than 0.3 on average
when compared to the reference values were considered to have no
effect. Combinations that resulted in a difference in Ct-values >0.3
on average were considered to show a high variability in Ct-values
(Karlen, McNair, Perseguers, Mazza, & Mermod, 2007). Any real-time
PCR curve deviating from a normal amplification curve was consid-
ered abnormal (see Figure 3 for normal and abnormal Bd and Bsal
amplification curves). All concentration combinations were assayed
in sextuplicate in a total of 4 real-time PCR runs.
2.5 | Validation of Bsal real-time PCR
Swab samples from 26 salamanders which had been experimentally
infected with Bsal, in addition to swabs from 12 non-infected con-
trols, were assayed. An aliquot of each DNA sample was provided to
four different laboratories, which performed the Bsal-specific real-
time PCR (laboratories 1–3) (Blooi et al., 2013) or droplet digital PCR
(ddPCR, laboratory 4). The Bsal ddPCR fractionates each sample into
20,000 nanolitre-sized water-in-oil droplets, with subsequent amplifi-
cation of the PCR target occurring within each of these droplets
(Hindson et al., 2011; Pinheiro et al., 2012). The number of target
copies in each individual droplet is determined, and based on Pois-
son statistics, the results generated by each individual droplet are
combined to calculate the overall number of target copies present in
the sample. This method is highly comparable in nature with the
more conventional Taqman probe PCRs, sharing reagents, sequence
of steps and run time, but with the defining feature of partitioning,
the sample in nano-sized droplets in which the target copies are
quantified. This similarity between the two methods justifies inclu-
sion of the ddPCR as validation for the Bsal qPCR. Therefore, the
results registered using this method were included in this repro-
ducibility study as they originated from a technique which is princi-
pally highly comparable to the Bsal-specific real-time PCR (Hindson
et al., 2011). The assay results from each laboratory were analysed
using the exact binomial test, t test, analysis of proportions and Ken-
dall’s correlation in the R statistical software. Diagnostic sensitivity
and diagnostic specificity of the results from each laboratory and
correlation among the laboratories were calculated and analysed. In
addition to analysing the correlation of genomic equivalents per sam-
ple detected in each laboratory, the genomic equivalents were con-
verted into binary data with positive samples being designated “1”
and negative samples being designated “0” and subjected to a t test
and also a comparison of proportions of the positive test results in
the four laboratories.
2.6 | Immunohistochemical detection of Bsal in
amphibian skin
2.6.1 | Production of polyclonal anti-Bsal and anti-
Bd antibodies
Polyclonal antibodies against Bd and Bsal were prepared by immuniz-
ing rabbits with Bd- and Bsal-antigen, respectively. Four bottles of
sporulating Bd were transferred to one tube while three bottles of
sporulating Bsal were transferred into another tube after which 3 ml
of HBSS was added to each tube. The protein concentration was
then determined by performing the BCA protein assay. In short, Bd
(strain JEL423) and Bsal (strain AMFP 13/1) antigen suspensions with
a concentration of 500 lg/ml antigen and 10 mg/ml Quil-A adjuvant
were prepared. Six rabbits were randomly split up in two groups, with
one group being immunized with Bd-antigen and the other with Bsal-
antigen. Each rabbit received 200 lg of antigen through subcuta-
neous injections (400 ll of antigen suspension divided over four
injection sites). Three booster immunizations, with identical antigen
concentrations, were administered after the primary immunization
with 14-day intervals. Blood collection of all rabbits took place prior
to immunization (negative control serum) and 7 days after the last
booster immunization (check for seroconversion in an indirect ELISA).
Blood samples were collected by venepuncture of the ear vein using
needles and syringes rinsed with heparin. After ascertaining serocon-
version against Bd- and Bsal-antigen with use of an indirect ELISA
assay, all rabbits were anaesthetized and euthanatized by exsanguina-
tion. Rabbit sera were separated and stored at 70°C.
In order to try to enhance the specificity of the polyclonal anti-
bodies against Bsal and Bd in the rabbit sera, Bsal-antisera were pre-
absorbed with Bd-antigen, and Bd-antisera were pre-absorbed with
Bsal-antigen. Suspensions containing mixed (meaning all life stages)
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cultures of Bd and Bsal at concentrations of 106 cells per ml were
sonicated and used as pre-absorbent. Bd-antisera and Bsal-antisera
were exposed to Bsal and Bd pre-absorbents respectively for an hour
at 37°C.
2.7 | Immunohistochemistry
The immunohistochemical assay for both Bsal and Bd was per-
formed as published previously for Bd (Hyatt et al., 2007). In addi-
tion, previously published methods to determine the optimal
concentration of the anti-Bsal and anti-Bd sera were used (Berger
et al., 2002), with the difference of testing the antisera on Bd and
Bsal cultures that were grown on glass inserts in 48-well plates,
instead of on agar. Occurrence of cross-reactivity of the antisera
against other fungi belonging to the Chytridiomycota phylum
(Homolaphlyctis polyrhiza, Rhizophlyctis rosea, Gaertneriomyces
semiglobifer, Rhizoclosmatium globosum, Podochytrium dentatum, Poly-
chytrium aggregatum, Geranomyces variabilis and Monoblepharis poly-
morpha) was tested.
Bsal- and Bd-positive skin tissues (as determined by positive
real-time PCR results and presence of Bd or Bsal in HE-stained his-
tology slides) preserved in neutral-buffered 10% formaldehyde were
used to verify the applicability of the immunohistochemical stain
and to test the specificity of the original and pre-absorbed antisera.
All of the tissue samples were stored in neutral-buffered 10%
formaldehyde for longer than 3 months, with the oldest samples
being stored in neutral-buffered 10% formaldehyde for more than
3 years.
3 | RESULTS
3.1 | Post-mortem detection of Bsal
The ability of histological examination and real-time PCR to detect
Bsal post-mortem in fire salamanders is summarized in Figure 1. All
individuals showed high infection loads with the real-time PCR
directly after death with swabs taken from the back (average of 4.4
log10 GE, SD of 0.14) and the abdomen (average of 3.8 log10 GE,
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F IGURE 1 Ability of histology and real-time PCR to detect Bsal post-mortem. Line-graphs (real-time PCR values) and tables (histology)
show the ability of the different techniques to detect Bsal post-mortem. Real-time PCR values are shown as genomic equivalents of Bsal per
swab. Results of histological examination are shown as Bsal positive (+), Bsal negative (), bacterially overgrown (BO) and no interpretation
possible (X). Different colours represent different individuals
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SD of 0.37) and with tissue taken from the tail (average of 4.5 log10
GE, SD of 0.60). During the 10-day follow-up period, fluctuation in
real-time PCR values was observed for all samples with most show-
ing a decrease in GE for the last 3 days each animal was sampled.
Bsal was detected on skin swabs taken from the back on average
until 7.2 days post-mortem (SD of 1.8), the abdomen until 5.8 days
post-mortem (SD of 3.0) and in tissue taken from the tail until
4.5 days post-mortem (SD of 0.6).
Histological examination of single skin preparations of tissue
samples taken from the back did not reveal presence of Bsal directly
after death in four of the five animals, while for single skin prepara-
tions of tissue samples taken from the abdomen two of the five ani-
mals did not show the presence of Bsal. Histological examination of
tissue samples failed to reveal presence of Bsal during the follow-up
phase in single skin preparations of tissue taken from the back for
one individual and in single skin preparations of tissue taken from
the abdomen for two individuals. Tissue samples taken from the
back were suitable for histological examination for 3.4 days on aver-
age (SD of 0.5), and samples taken from the abdomen for 2.4 days
on average (SD of 0.5), after which autolysis and/or (partial) absence
of epidermis made histological examination impossible (see Figure 2).
3.2 | Latency time of the Bsal real-time PCR
Bsal infections took 2–3 weeks post-exposure to a low dose (100
spores/ml) of Bsal spores to manifest as detectable via PCR (see
Table 1).
3.3 | Competition between detection of Bd and
Bsal in the duplex real-time PCR
In most combinations, no effect on the detectability of both Bd and
Bsal could be observed. However, at some combinations where one
pathogen’s load was 10 to 10,000 times higher than the other, the
pathogen in lower concentration could not be detected (see
Table 2). Also, at some of these combinations where one pathogen
outnumbered the second by 10 to 100 times, high variability in Ct-
values or abnormal curves was observed (see Figure 3 for normal
and abnormal amplification curves). Test sensitivity was higher in the
absence of the other pathogen.
3.4 | Validation of Bsal-specific real-time PCR
(diagnostic sensitivity, diagnostic specificity and
reproducibility)
Two of the laboratories demonstrated perfect diagnostic sensitivity
while samples with very low GE proved challenging for the other
two laboratories. In laboratories 1 and 2, the calculated diagnostic
sensitivity is 100% (95% CI: 86.6%–100%), while it is 96.2% (95%
CI: 80.4%–99.9%) and 92.3% (95% CI: 75%–99%) in laboratories 3
and 4 (ddPCR) respectively using the exact binomial test.
(a) (b)
(c) (d)
F IGURE 2 Haematoxylin and eosin
(HE)-stained histological skin sections of
fire salamanders infected with Bsal.
Haematoxylin and eosin (HE)-stained 5-lm
skin sections were prepared from tissue
samples taken from the back and the
abdomen of the fire salamanders that died
due to infection with Bsal, in order to
reveal presence of Bsal. (a) Multiple Bsal
thalli present in the skin directly after
death, (b and c) multiple Bsal thalli
together with bacterial overgrowth and
partial loss of the epidermis 2–3 days after
death and (d) skin section lacking the
complete epidermis 3–4 days after death.
Arrow heads are used to indicated Bsal
thalli. SC, stratum corneum; SG, stratum
germinativum; SS, stratum spongiosum
TABLE 1 The latency time to detect Bsal with the Bsal-specific
real-time PCR in fire salamanders that were exposed to a low dose
of Bsal spores
D0 D7 D14 D21 D28
Bsal positive – 0/26 20/26 26/26 26/26
Bsal load
(average
[min–max])
– 0 (0–0) 778.7
(0–5,140)
1711.9
(8.4–6,700)
5,888
(22.6–
19,990)
Twenty-six fire salamanders were exposed to 102 Bsal spores at D0 and
subsequently checked for detectable presence of Bsal with real-time PCR
on a 7-day interval. Real-time PCR values are shown as genomic equiva-
lents of Bsal per swab.
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3.5 | All four laboratories demonstrated perfect
diagnostic specificity, 100% (95% CI: 73%–100%)
with the exact binomial test
In terms of reproducibility, both the statistical tests analysing the
performance of the laboratories based on the positive or negative
status of each sample and the tests analysing the quantification of
genomic equivalents in each sample demonstrated very high levels
of reproducibility among laboratories and/or among operators (see
Figure 4 and Tables 3 and 4). A t test and analysis of proportions of
positive tests revealed that there were no significant differences in
proportions of samples detected as positive in all four laboratories
(see Table 3), confirming the congruence of the results of the Bsal
real-time PCR assay. In laboratories 1 and 2, all true-positive samples
yielded positive results (26/26), and in laboratories 3 and 4, (25/26)
positive samples and (24/26) true-positive samples tested positive,
respectively. Kendall’s correlation coefficient indicates very strong
correlation in GE (values are very close to 1) among all the laborato-
ries (see Table 4). The highest correlation exists between laborato-
ries 1 and 4 (0.912), and all laboratories have ≥80% correlation
which confirms a strong to very strong correlation among the results
from all four laboratories.
3.6 | Immunohistochemical detection of Bsal in the
amphibian skin
The indirect ELISA and efforts at determining the optimal concentra-
tion of both Bsal- and Bd-antisera showed high levels of reactivity,
without showing specificity for Bsal or Bd. All antisera showed com-
parable levels of reactivity, and antisera derived from one rabbit
immunized with Bsal and one rabbit immunized with Bd were chosen
to further test the applicability of the antisera on amphibian skin
samples. Pre-absorption of the antisera (pre-absorption of Bsal-anti-
sera with Bd-antigen and vice versa) did not increase specificity. The
concentrations at which clear immunohistochemical staining of Bsal
and Bd cultures occurred, with low levels of background staining,
were at a dilution of 1/5,000 and 1/2,000 for tissue sections. For
the other tested Chytridiomycota, slight cross-reactivity was
observed for Homolaphlyctis polyrrhiza for both the Bd- and Bsal-anti-
sera. All tissue samples that were histologically positive (as deter-
mined with HE-staining) for Bd or Bsal showed clear
immunohistochemical staining of Bd or Bsal (Figure 5), with no detri-
mental effect of long-term storage of samples in 10% formaldehyde
occurring.
4 | DISCUSSION
Rapid diagnosis of disease and detection of pathogens are essential
elements in controlling emerging infections, enabling responses such
as specific containment measures or restrictions of movement to be
implemented (Morens, Folkers, & Fauci, 2004). Therefore, shortly
after Bsal was identified as an infectious agent capable of causing
chytridiomycosis in amphibians (Martel et al., 2013, 2014), research
efforts towards developing diagnostic tools that allowed rapid and
reliable detection of Bsal were instigated (Blooi et al., 2013). The
Bsal qPCR was subsequently developed and has since filled this diag-
nostic need. This assay has the advantage over the diagnostic meth-
ods histology, PCR and lateral flow assay of being able to
simultaneously identify and quantify the Bsal pathogen in amphibian
TABLE 2 Competition between detection of Bd and Bsal in the
duplex real-time PCR
Combination Bsal Bd
Bd 500/Bsal 500 No effect No effect
Bd 500/Bsal 50 High variability in
Ct-values + Abnormal curves
No effect
Bd 500/Bsal 5 Failure to detect No effect
Bd 500/Bsal 0.5 Failure to detect No effect
Bd 500/Bsal 0.05 Failure to detect No effect
Bd 50/Bsal 500 No effect No effect
Bd 50/Bsal 50 No effect No effect
Bd 50/Bsal 5 No effect No effect
Bd 50/Bsal 0.5 Failure to detect No effect
Bd 50/Bsal 0.05 Failure to detect No effect
Bd 5/Bsal 500 No effect High variability in
Ct-values +
Abnormal curves
Bd 5/Bsal 50 No effect No effect
Bd 5/Bsal 5 No effect No effect
Bd 5/Bsal 0.5 High variability in
Ct-values + Abnormal curves
No effect
Bd 5/Bsal 0.05 Failure to detect No effect
Bd 0.5/Bsal 500 No effect Failure to detect
Bd 0.5/Bsal 50 No effect High variability in
Ct-values +
Abnormal curves
Bd 0.5/Bsal 5 No effect No effect
Bd 0.5/Bsal 0.5 No effect No effect
Bd 0.5/Bsal 0.05 High variability in
Ct-values + Abnormal curves
No effect
Bd 0.05/Bsal 500 No effect Failure to detect
Bd 0.05/Bsal 50 No effect Failure to detect
Bd 0.05/Bsal 5 No effect Failure to detect
Bd 0.05/Bsal 0.5 No effect High variability in
Ct-values +
Abnormal curves
Bd 0.05/Bsal 0.05 No effect No effect
All real-time PCR values obtained for the different combinations were
compared to baseline reference values composed of real-time PCR values
of Bd and Bsal obtained in the absence of the other pathogen. Combina-
tions in which the difference in Ct-values was smaller than 0.3 Ct-values
on average when compared to the reference values were considered to
have no effect. Combinations that resulted in a difference in Ct-values
>0.3 on average were considered to show a high variability in Ct-values.
Any real-time PCR curve deviating from a normal amplification curve was
considered abnormal.
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samples (Berger, Speare, & Kent, 1999; Dillon et al., 2017; Martel
et al., 2013). Based on our validation study, the Bsal-specific real-
time PCR assay has demonstrated diagnostic sensitivity of 96.2%–
100% (qPCR), 92.3% (ddPCR) and perfect specificity (100%) across
all four laboratories. Like the duplex real-time PCR, the Bsal real-time
PCR allows Bsal diagnosis with quantification of GE with a very high
degree of sensitivity and specificity using non-invasively collected
swabs and does not require specialist expertise. This study
establishes that the Bsal real-time PCR has also demonstrated very
high reproducibility both in terms of determining positive and nega-
tive samples and in the number of genomic equivalents detected
across laboratories. It can thus be used to confirm negative Bsal test
results from duplex real-time PCR assays where high GEs of Bd have
been detected and negative histology-based tests such as immuno-
histochemistry and H&E tests. These characteristics indicate that this
test is an extremely valuable tool in the arsenal of researchers,
F IGURE 3 Amplification curves of the
Bd and Bsal duplex real-time PCR.
Amplification plot (variation of log RFU
with each PCR cycle number) showing
normal and abnormal amplification curves
as they can be observed with the duplex
real-time PCR. Blue lines depict the Bd
component of the duplex real-time PCR,
and purple lines depict the Bsal component
of the duplex real-time PCR. Normal real-
time PCR curves show an exponential
increase in fluorescence as indicated by a
smooth linear phase in the amplification
plots. The threshold should be set halfway
in the linear phase of the amplification
curves
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F IGURE 4 Comparison of genomic
equivalents (GE) among laboratories 1–4.
Scatter plot representing correlation
between genomic equivalents by pairs of
laboratories. All pairs demonstrate a strong
to very strong positive correlation
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laboratories, clinicians and governmental agencies in identifying
novel cases of Bsal, determining its dispersal and implementation of
mitigation and/or prophylactic measures to contain its spread. The
discovery that this test is able to detect Bsal in some hosts exposed
to low fungal doses (100 spores) between 2 and 3 weeks post-expo-
sure indicates its diagnostic efficacy and also provides a timeline
where amphibians which have tested negative may be retested with
even more reliable outcomes. The implications are monumental for
disease prevention in na€ıve regions.
The developed Bsal- and Bd species-specific duplex real-time
PCR allows detection of both pathogens on non-invasively col-
lected amphibian samples. Furthermore, this test can easily be
implemented by diagnostic laboratories, without the need for spe-
cialist expertise and experience required for accurate interpretation
of alternative diagnostic tools for identifying the presence of
chytrid fungi such as histology (Berger et al., 1999; Hyatt et al.,
2007).
During the extensive use of the duplex real-time PCR (over
8,000 amphibian swab and tissue samples have been processed to
date in our laboratory [Laking et al., 2017; Martel et al., 2014; Spit-
zen-van der Sluijs et al., 2016]), only rare incidents have occurred in
which abnormal results have been obtained. One issue concerning
the duplex real-time PCR is outlined in Table 2, namely that large
differences in concentration between pathogens tended to lead to
the lower concentration pathogen not being detected efficiently. We
suggest that simplex Bd or Bsal assays are performed to confirm the
true absence of the respective pathogen in amphibian samples, when
the other pathogen is detected.
Another issue concerning the duplex real-time PCR was noted
when the assay was used in post-mortem detection of Bsal. Repeated
borderline positive results (Ct-values corresponding with GE values
around or lower than 0.1 GE of Bsal) were obtained with the real-time
PCR when it was applied to detect Bsal in amphibians (Alpine newts
[Ichtyosaura alpestris]) post-mortem. Bsal’s presence could not be con-
firmed with other diagnostic tools (histopathology and immunohistol-
ogy), and sequencing did not confirm the presence of Bsal. In most
cases, these results were associated with abnormal amplification
curves, but normal amplification curves were occasionally observed
as well (Figure 3). Therefore, when used as a post-mortem diagnostic
tool, we suggest to elevate the detection limit to 1.0 GE of Bsal
instead of 0.1 GE of Bsal, thus preventing an animal to be wrongly
designated as Bsal positive. Furthermore, we stress that molecular
diagnostic tools such as the duplex real-time PCR should be used in
conjunction with techniques that are able to show colonization and/
or pathology such as histology or histopathology, where able.
We found that the duplex real-time PCR is valuable as a post-
mortem screening tool for Bsal (see Figure 1). Swab samples taken
TABLE 3 Comparison of laboratories (t test) based on proportion
of positive results from total samples
Laboratories
Proportion of positive
results/total samples
Proportion of positive
results/total samples p-value
Laboratories
1–2
Laboratory 1 0.684 Laboratory 2 0.684 1
Laboratories
1–3
Laboratory 1 0.684 Laboratory 3 0.658 .8102
Laboratories
1–4
Laboratory 1 0.684 Laboratory 4 0.632 .6341
Laboratories
2–3
Laboratory 2 0.684 Laboratory 3 0.658 .8102
Laboratories
2–4
Laboratory 2 0.684 Laboratory 4 0.632 .6341
Laboratories
3–4
Laboratory 3 0.657 Laboratory 4 0.632 .8136
Comparison of proportions of positive results from total number of sam-
ples among four laboratories. The laboratories were paired, and all partic-
ipating laboratories’ proportions were compared. The proportions were
comparable as the detection of Bsal in the positive samples was 26/26
for laboratories 1&2 and 25/26 and 24/26 for laboratories 3&4, respec-
tively.
TABLE 4 Kendall’s correlation matrix of Bsal qPCR assay results
(GE) in four laboratories
Laboratory
1
Laboratory
2
Laboratory
3
Laboratory
4
Laboratory 1 1.000 0.910 0.808 0.912
Laboratory 2 0.910 1.000 0.801 0.895
Laboratory 3 0.808 0.801 1.000 0.801
Laboratory 4 0.912 0.895 0.801 1.000
The results (genomic equivalents) of the Bsal qPCR assays performed in
the four laboratories were analysed using a Kendall’s correlation test and
compared in a Kendall’s correlation matrix to demonstrate the level of
correlation between the number of genomic equivalents detected in each
sample in each laboratory.
F IGURE 5 Immunohistochemical microscopy of a fire salamander
with Bsal infection. Immunohistochemical staining of Bsal
intracellular colonial thalli in a degraded epidermal layer
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from the back and abdomen and analysed with the duplex real-time
PCR were able to detect Bsal on average for up to 7.2 days and
5.8 days after death, respectively. For tail tissue samples, post-mor-
tem detectability was shorter with 4.5 days on average. This shows
that despite advanced stages of decomposition (which occurred in all
animals between 3 and 6 days post-mortem), the duplex real-time
PCR is still able to detect Bsal, when animals have died due to Bsal
infection (thus having a high Bsal infection load at time of death).
Skin decomposition was found to affect diagnostic value of histologi-
cal samples more rapidly, making the duplex real-time PCR a com-
paratively more sensitive method to show the presence of Bsal post-
mortem.
Although histological examination failed to identify the presence
of Bsal in most samples in this study (Figure 1), it should be noted
that only single skin preparations were histologically assayed and
that these preparations may not have been performed on samples
from areas of the skin where there were Bsal lesions, whereas a
higher probability of detection of chytrids can be obtained by exam-
ining multiple skin sections (Berger et al., 1999; Puschendorf &
Bola~nos, 2006; Skerratt et al., 2011).
Regardless of the technique used to detect Bsal post-mortem, on
average, samples taken from the back had the longest detectability
or in case of histology, the best chance of detecting Bsal (meaning
presence of epidermis without autolysis obstructing histopathological
examination). We believe that this can be attributed to more rapid
degradation of DNA in the ventral area (as can be seen by the loss
of dermal structure in the histological samples) which was in direct
contact with soil and associated soil microorganisms. It has to be
noted, however, that post-mortem detectability was assayed under
experimental conditions. Therefore, environmental conditions such
as temperature and/or humidity fluctuation or exposure to direct
sunlight, which may also affect post-mortem detectability of Bsal,
could not be taken into account.
For detection of Bsal in older and/or stored samples, histology
does have an advantage over molecular methods such as real-time
PCR. For instance, storage for months to years in neutral-buffered
formaldehyde does not affect tissue morphology nor does it affect
the ability of the immunohistochemical staining technique to detect
Bsal (Figure 5).Whereas, detection of DNA in these stored samples
utilizing genomic detection methods is challenging and often
obstructed due to tissue lysis and/or DNA damage (Wandeler,
Hoeck, & Keller, 2007; Zimmermann et al., 2008). Although proto-
cols have been developed to circumvent issues with detecting chy-
trid DNA in archived samples, real-time PCR inhibition affecting
accurate quantification still occurs to some extent and procedures
are laborious (Adams et al., 2015). Instead, chytrid-specific
 Application       Recommendations 
 Screening live animals (1) Use the protocols for sampling, DNA extraction and PCR execution as described in Blooi et al. (2013). 
(2) Verify assay performance (precision, efficiency and linear correlation) using quantification standards of both Bd and Bsal as described in 
Blooi et al. (2013), and set the threshold halfway in the linear phase of the amplification curve. 
(3) Run all samples in duplicate. Interpret samples as: 
Positive:  
- Ct-values for both wells, or in three of four wells when a sample is rerun (see further down) 
- Normal amplification curves for all positive wells  
- Low variability between the duplicate (< 0.3 Ct-value) 
- Ct-values corresponding to GE-values ≥ 1 GE of Bsal
Negative: 
- No Ct-values for both wells, or in two or less out of four wells when a sample is rerun 
- Ct-values corresponding to GE-values <1 GE of Bsal 
Ambiguous: 
- Ct-value in only one well 
- Abnormal amplification curves 
- High variability between the duplicate (> 0.3 Ct-value) 
- Presence of only Bd or only Bsal
For all ambiguous samples, rerun the sample in duplicate and try to verify true presence/absence by sequencing and/or histology. In case 
the issue remains unresolved, repeat the sample collection and PCR analyses.  
For samples that show the presensce of only Bd or only Bsal, a simplex assay should be run to verify true absence of the other  
pathogen. 
 Post-mortem screening (1) Collect skin swabs from the back (dorsal) side of the animal (side that has not been in contact with substrate) as soon as possible, but no 
longer than 5 days after death of the animal. 
(2) Uphold the recommendations for screening live animals, but with a cut-off for Bsal-positive samples of Ct-values corresponding to 1.0 
GE of Bsal instead of 0.1 GE of Bsal. 
(3) Confirm the presence of disease lesions by histopathology. (Samples should preferably be taken from the areas of the skin with obvious 
lesions.) 
F IGURE 6 Summary of the recommendations on the use of the duplex real-time PCR for Bd and Bsal. Recommendations on sampling,
assaying and interpreting results of samples tested using the duplex real-time PCR for simultaneous detection of Bsal and Bd
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histological staining techniques are useful tools to allow visualization
of chytrids without the need for expertise in identifying chytrid
stages present in the skin (Berger et al., 2002).
Although previously described, polyclonal antibodies against Bd
and the polyclonal Bsal antibodies generated in this study were
found not to be species-specific (even after antigen pre-absorption
of antibodies). Several parameters were investigated to determine
whether the specificity could be enhanced (longer incubation time,
increased antigen content, increased antibody concentration and
whole-cell pre-absorption); however, none of these tests were suc-
cessful. Therefore, we are inclined to believe that most of the anti-
gens to which the antibodies respond are common to Bd and Bsal. In
a case like this, however, differences in pathology associated with
infections of Bd and Bsal still allow for differentiation between the
two pathogens in amphibian samples (White et al., 2016). A sum-
mary of our recommendations concerning the duplex real-time PCR
for Bsal can be found in Figure 6.
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